First Trust Direct Indexing’s CONMED CNMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-1,971
Closed -$216K 823
2023
Q4
$216K Buy
+1,971
New +$204K 0.02% 686
2023
Q3
Sell
-1,498
Closed -$204K 707
2023
Q2
$204K Buy
+1,498
New +$183K 0.02% 658
2022
Q2
Sell
-1,506
Closed -$224K 651
2022
Q1
$224K Sell
1,506
-26
-2% -$3.63K 0.03% 590
2021
Q4
$217K Buy
+1,532
New +$217K 0.03% 587
2021
Q1
Sell
-979
Closed -$110K 510
2020
Q4
$110K Buy
+979
New +$92.7K 0.03% 474

Other funds holding CNMD

First Trust Direct Indexing's CNMD Position: Q1 2024 in Review

First Trust Direct Indexing sold out of CONMED (CNMD) in Q1 2024, closing a stake of 1,971 shares — an estimated $216K sold.

First Trust Direct Indexing first reported a position in CNMD in Q4 2020 and held it in 5 quarters. The position peaked at $224K in Q1 2022. 298 funds tracked by Wall St. Rank hold CNMD as of Q1 2024.

  • First Trust Direct Indexing reported no remaining CONMED position as of Q1 2024 after selling out during the quarter.
  • First Trust Direct Indexing sold 1,971 CONMED shares in Q1 2024, an estimated $216K.
  • First Trust Direct Indexing first reported a position in CONMED in Q4 2020 and held it in 5 quarters.
  • First Trust Direct Indexing's CONMED position peaked at $224K in Q1 2022.
  • 298 funds tracked by Wall St. Rank held CONMED as of Q1 2024.

Based on First Trust Direct Indexing's 13F filing for Q1 2024, filed 19 Apr 2024.